title: Breast Cancer Survival at a Leading Cancer Centre in Malaysia.
abstract: BACKGROUND
  GLOBOCAN12 recently reported high cancer mortality in Malaysia suggesting its cancer health services are under-performing. Cancer survival is a key index of the overall effectiveness of health services in the management of patients. This report focuses on Subang Jaya Medical Centre (SJMC) care performance as measured by patient survival outcome for up to 5 years.
  
  
  METHODS
  All women with breast cancer treated at SJMC between 2008 and 2012 were enrolled for this observational cohort study. Mortality outcome was ascertained through record linkage with national death register, linkage with hospital registration system and finally through direct contact by phone or home visits.
  
  
  RESULTS
  A total of 675 patients treated between 2008 and 2012 were included in the present survival analysis, 65% with early breast cancer, 20% with locally advanced breast cancer (LABC) and 4% with metastatic breast cancer (MBC). The overall relative survival (RS) at 5 years was 88%. RS for stage I was 100% and for stage II, III and IV disease was 95%, 69% and 36% respectively.
  
  
  CONCLUSIONS
  SJMC is among the first hospitals in Malaysia to embark on routine measurement of the performance of its cancer care services and its results are comparable to any leading centers in developed countries.
authors.affiliation: Cancer and Radiosurgery Centre, Subang Jaya Medical Centre, Subang Jaya, Malaysia E-mail : matinmellor@yahoo.com.
authors.forename: Matin Mellor
authors.initials: MM
authors.lastname: Abdullah
authors.forename: Ahmad Kamal
authors.initials: AK
authors.lastname: Mohamed
authors.forename: Yoke Ching
authors.initials: YC
authors.lastname: Foo
authors.forename: Catherine May Ling
authors.initials: CM
authors.lastname: Lee
authors.forename: Chin Teong
authors.initials: CT
authors.lastname: Chua
authors.forename: Chin Huei
authors.initials: CH
authors.lastname: Wu
authors.forename: Lp
authors.initials: L
authors.lastname: Hoo
authors.forename: Teck Onn
authors.initials: TO
authors.lastname: Lim
authors.forename: Sze Whey
authors.initials: SW
authors.lastname: Yen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D002173:Cancer Care Facilities; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D015331:Cohort Studies; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008296:Malaysia; D008875:Middle Aged; D060787:Neoplasm Grading; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D011379:Prognosis; D015996:Survival Rate; D055815:Young Adult